MNNGF (Baijin Life Science Holdings) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 25, 2026)


MNNGF Baijin Life Science Holdings Ltd MNNGF
35 GF Score
Price $0.08
GF Value $0.04
! 6 Warning Signs
View Full Analysis

What is Baijin Life Science Holdings Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Baijin Life Science Holdings's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

MNNGF vs TPR: Margin of Safety % (DCF Earnings Based) Comparison

For the Luxury Goods subindustry, Baijin Life Science Holdings's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Baijin Life Science Holdings Margin of Safety % (DCF Earnings Based) vs Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Baijin Life Science Holdings's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Baijin Life Science Holdings's Margin of Safety % (DCF Earnings Based) falls into.


MNNGF
35GF Score
Baijin Life Science Holdings Ltd MNNGF
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Baijin Life Science Holdings (MNNGF) Overvalued in 2026?

Based on GuruFocus' analysis, Baijin Life Science Holdings stock appears to be overvalued. The current stock price of $0.08 is trading 87.5% above its estimated GF Value™ of $0.04.

Key valuation signals for MNNGF:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: $0.04 vs. price of $0.08 (87.5% above fair value)
  • GF Score™: 35/100 with 6 warning signs

No single metric tells the full story. See the MNNGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Baijin Life Science Holdings Business Description

Other Exchanges 01466:Hong Kong
Address 66 Gloucester Road, Office B, 9/F Pico Tower, Wanchai, Hong Kong, HKG
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company has three business segment: jewelry business segment; strategic investment segment; and skincare business segment. The majority of revenue is coming from jewelry business segment.
35GF Score

Get the complete analysis for MNNGF

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price
$0.04
GF Value